Skip to Main Content

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease


Diseases of the Nervous System

Phase III

What is the purpose of this trial?

Brief Summary:

This is a multicenter, randomized, open-label study with an active standard-of-care comparator (penicillamine)

  • Trial with
    Gmp-Orphan France SA
  • Start Date
  • End Date
Trial Image

For more information about this study, contact:

Daksshi Hettiarachchi

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC